| sop_id | SOP-007 |
|---|---|
| title | Medical Device File Control |
| revision | R10 |
| revision_date | 2026-05-04 |
| status | Published |
| owner_role | management_representative |
| approver_role | qa_lead |
| related_issue | #3 |
Define structure, ownership, and control of product-specific medical device files (MDF) as the technical documentation set required for ACME software products under applicable medical device regulations, including EU MDR Annex II/III and equivalent design-history-file expectations.
Applies to each product that qualifies as medical device software under applicable regulatory requirements. Regulatory applicability, including jurisdictions and frameworks such as EU MDR, UK MDR/UKCA, Swiss MedDO, US FDA regulations, and MDSAP-participating markets, is defined and maintained in the regulatory scope baseline. Product MDF records are maintained in designated product or study repositories, not in dearauditor-qms-baseline.
- Product intended use and claims
- Classification rationale and regulatory pathway
- Design, risk, verification/validation, and post-market artifacts
- Controlled product MDF index and current artifact set
- Traceable linkage between requirements, risks, tests, releases, and post-market records
| Role | Responsibilities |
|---|---|
| Management Representative | Ensures MDF completeness and regulatory coherence. |
| Engineering Lead | Maintains technical artifact currency and release traceability references. |
| QA Lead | Verifies file control and traceability quality. |
The MDF shall reflect the configuration of each released product version and remain traceable to the corresponding approved release baseline.
Each product MDF must include at minimum:
- Intended use, claims, users, and contraindications
- Qualification/classification rationale by jurisdiction
- Requirements and architecture references
- Risk management file references
- Verification/validation summary and traceability
- Release history and post-market references
- Repository path/structure that identifies where controlled MDF records are maintained
- Clinical or performance evaluation references where applicable
- Accompanying information, including instructions for use, user-facing labeling, and technical description, controlled per
records/mdf/accompanying_information_template.mdor an equivalent product-specific record - Usability engineering file references where applicable
- Cybersecurity and data protection considerations where applicable
- Retirement, decommissioning, or disposal record reference for the released product where applicable, controlled under
SOP-020
- Company QMS is generic; product-specific intended use/classification is never inferred from company-level SOPs.
- Each product must define its own infrastructure and operational controls in product architecture documentation.
- MDF-impacting changes must be assessed in product change records.
- Regulatory-impacting changes require documented pathway reassessment.
- MDF index must be updated before release in the designated record repository.
- GitHub issue/PR workflow and post-merge signature attestation are used as the approval evidence model for released MDF records.
- Product release shall not proceed unless the MDF is complete and current, including documented requirements traceability, risk-management evidence with residual risk acceptability, and verification/validation evidence demonstrating conformity to intended use and applicable regulatory requirements.
- Review MDF completeness at least quarterly and before major release.
- Resolve missing/obsolete artifact references via CAPA or change control.
- Product MDF index and change history in the designated product/study repository
- Classification and regulatory decision records
- Traceability summary evidence
| Standard Clause | Control in this SOP |
|---|---|
| ISO 13485:2016 4.2.3 | Defines content and control expectations for the medical device file per product. |
- SOP-008 Design and Development Control
- SOP-009 Change Management
- SOP-014 Post-Market Surveillance
| Revision | Revision Date | Change Summary |
|---|---|---|
| R00 | 2026-03-02 | Initial full release. |
| R01 | 2026-03-05 | Clarified that product MDF records are maintained in designated product/study repositories and aligned release evidence model with GitHub PR plus post-merge signature attestation. |
| R02 | 2026-03-07 | Normalized responsibility labels to the controlled small-team role model and clarified engineering ownership of MDF technical traceability. |
| R03 | 2026-03-07 | Renamed the accountable engineering role to engineering_lead in the simplified role taxonomy. |
| R04 | 2026-03-07 | Removed overly specific signature-regulation terminology from the MDF approval evidence wording. |
| R05 | 2026-03-10 | Updated the upstream baseline repository naming reference used for product MDF record separation guidance. |
| R06 | 2026-03-18 | Removed top-table standards clause metadata; normative references remain in the Traceability section. |
| R07 | 2026-03-25 | Expanded MDF scope and minimum content to cover technical-documentation expectations, release-baseline traceability, and release-readiness evidence. |
| R08 | 2026-04-25 | Made accompanying information (IFU, user-facing labeling, technical description) and product retirement/decommissioning explicit minimum MDF content with controlled template references for IEC 82304-1:2016 clauses 7 and 8. |
| R09 | 2026-04-27 | Renamed YAML metadata field effective_date to revision_date to align controlled-document metadata with the tag-based publication model. The effective date is derived from the published QMS release tag rather than from the document front matter. |
| R10 | 2026-05-04 | Standardize standards citations to specific versions. |